D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Chemistry D-index 61 Citations 10,620 317 World Ranking 6158 National Ranking 58
Biology and Biochemistry D-index 64 Citations 11,218 316 World Ranking 6419 National Ranking 27

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Enzyme
  • Organic chemistry

Stereochemistry, Pharmacology, Biochemistry, Cytotoxicity and Chemical synthesis are his primary areas of study. The various areas that he examines in his Stereochemistry study include Biological activity, 1,4-Naphthoquinone, Structure–activity relationship and Mechanism of action. His Pharmacology study incorporates themes from Superoxide, Nitric oxide, Immunology and Soluble guanylyl cyclase.

As a member of one scientific family, Sheng-Chu Kuo mostly works in the field of Biochemistry, focusing on Platelet and, on occasion, Phosphodiesterase. His Cytotoxicity study results in a more complete grasp of In vitro. His In vitro research is multidisciplinary, relying on both Cell culture and Aryl.

His most cited work include:

  • YC-1, a novel activator of platelet guanylate cyclase. (432 citations)
  • 6-Alkylamino- and 2,3-dihydro-3'-methoxy-2-phenyl-4-quinazolinones and related compounds: their synthesis, cytotoxicity, and inhibition of tubulin polymerization. (322 citations)
  • YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase. (223 citations)

What are the main themes of his work throughout his whole career to date?

Sheng-Chu Kuo spends much of his time researching Stereochemistry, Pharmacology, Apoptosis, Cancer research and Biochemistry. The Stereochemistry study combines topics in areas such as Lead compound, In vitro, Chemical synthesis and Cytotoxicity. His work deals with themes such as Cell culture and Structure–activity relationship, which intersect with Cytotoxicity.

His biological study spans a wide range of topics, including Platelet and Mechanism of action. The study incorporates disciplines such as Molecular biology, Cell growth and Cell biology in addition to Apoptosis. His study in Cancer research is interdisciplinary in nature, drawing from both Cancer cell, Cancer, Internal medicine and Protein kinase B.

He most often published in these fields:

  • Stereochemistry (21.91%)
  • Pharmacology (19.65%)
  • Apoptosis (18.89%)

What were the highlights of his more recent work (between 2012-2021)?

  • Cancer research (14.86%)
  • Pharmacology (19.65%)
  • Apoptosis (18.89%)

In recent papers he was focusing on the following fields of study:

Sheng-Chu Kuo focuses on Cancer research, Pharmacology, Apoptosis, Cancer cell and Cell cycle. His Cancer research research integrates issues from Cyclin-dependent kinase 1, Curcumin, Breast cancer and In vivo. Sheng-Chu Kuo interconnects Cell culture, Mechanism of action, Potency, Cytotoxicity and Structure–activity relationship in the investigation of issues within Pharmacology.

Sheng-Chu Kuo has researched Apoptosis in several fields, including Indazole, Signal transduction, Cell biology and Cell growth. His Cell biology research includes elements of Molecular biology and Programmed cell death. His studies in Stereochemistry integrate themes in fields like Lead compound and Methylenedioxy.

Between 2012 and 2021, his most popular works were:

  • Yuwen02f1 suppresses LPS-induced endotoxemia and adjuvant-induced arthritis primarily through blockade of ROS formation, NFkB and MAPK activation. (63 citations)
  • EGFR Modulates DNA Synthesis and Repair through Tyr Phosphorylation of Histone H4 (53 citations)
  • Curcumin suppresses doxorubicin-induced epithelial-mesenchymal transition via the inhibition of TGF-β and PI3K/AKT signaling pathways in triple-negative breast cancer cells. (51 citations)

In his most recent research, the most cited papers focused on:

  • Enzyme
  • Gene
  • Organic chemistry

His primary areas of study are Pharmacology, Apoptosis, Cancer research, Cell biology and Cancer cell. The concepts of his Pharmacology study are interwoven with issues in Cell culture, Inflammation, Immunology, Glycoside and Structure–activity relationship. His research integrates issues of Indazole, Biological evaluation, Carbazole and Tricyclic in his study of Apoptosis.

His Cancer research study combines topics from a wide range of disciplines, such as Curcumin, Histone, Downregulation and upregulation and MAPK/ERK pathway. His Cell biology research is multidisciplinary, incorporating elements of Cyclin-dependent kinase 1 and Programmed cell death. In his research on the topic of Cytotoxicity, Stereochemistry is strongly related with Cell sorting.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

YC-1, a novel activator of platelet guanylate cyclase.

Feng-Nien Ko;Chin-Chung Wu;Sheng-Chu Kuo;Fang-Yu Lee.
Blood (1994)

692 Citations

6-Alkylamino- and 2,3-dihydro-3'-methoxy-2-phenyl-4-quinazolinones and related compounds: their synthesis, cytotoxicity, and inhibition of tubulin polymerization.

Mann-Jen Hour;Li-Jiau Huang;Sheng-Chu Kuo;Yi Xia.
Journal of Medicinal Chemistry (2000)

485 Citations

YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase.

Chin-Chung Wu;Feng-Nien Ko;Sheng-Chu Kuo;Fang-Yu Lee.
British Journal of Pharmacology (1995)

342 Citations

Studies on heterocyclic compounds. 6. Synthesis and analgesic and antiinflammatory activities of 3,4-dimethylpyrano[2,3-c]pyrazol-6-one derivatives.

S.-C. Kuo;L.-J. Huang;H. Nakamura.
Journal of Medicinal Chemistry (1984)

316 Citations

Antitumor Agents. 181. † Synthesis and Biological Evaluation of 6,7,2',3',4'-Substituted-1,2,3,4-tetrahydro-2-phenyl-4-quinolones as a New Class of Antimitotic Antitumor Agents

Yi Xia;Zheng Yu Yang;Peng Xia;Kenneth F. Bastow.
Journal of Medicinal Chemistry (1998)

310 Citations

Synthesis and cytotoxicity of 1,6,7,8-substituted 2-(4'-substituted phenyl)-4-quinolones and related compounds: Identification as antimitotic agents interacting with tubulin

Sheng Chu Kuo;Hong Zin Lee;Jung Pin Juang;Yih Tyng Lin.
Journal of Medicinal Chemistry (1993)

273 Citations

Antitumor Agents. Part 204: Synthesis and Biological Evaluation of Substituted 2-Aryl Quinazolinones

Yi Xia;Zheng Yu Yang;Mann Jen Hour;Sheng Chu Kuo.
Bioorganic & Medicinal Chemistry Letters (2001)

256 Citations

Three new flavonoids and antiallergic, anti-inflammatory constituents from the heartwood of Dalbergia odorifera.

Shiuh-Chuan Chan;Yuan-Shiun Chang;Jih-Pyang Wang;Sheng-Chih Chen.
Planta Medica (1998)

223 Citations

Antiplatelet components in Panax ginseng.

Sheng-Chu Kuo;Che-Ming Teng;Jang-Chang Lee;Feng-Nien Ko.
Planta Medica (1990)

181 Citations

Antioxidant properties of butein isolated from Dalbergia odorifera

Zhi-Jiao Cheng;Sheng-Chu Kuo;Shiuh-Chuan Chan;Feng-Nien Ko.
Biochimica et Biophysica Acta (1998)

164 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Sheng-Chu Kuo

Jai Sing Yang

Jai Sing Yang

China Medical University

Publications: 101

Jing Gung Chung

Jing Gung Chung

China Medical University

Publications: 81

Kuo Hsiung Lee

Kuo Hsiung Lee

China Medical University

Publications: 42

Che-Ming Teng

Che-Ming Teng

National Taiwan University

Publications: 37

Michael A. Marletta

Michael A. Marletta

University of California, Berkeley

Publications: 23

Tsong-Long Hwang

Tsong-Long Hwang

Chang Gung University of Science and Technology

Publications: 21

Chih-Hsin Tang

Chih-Hsin Tang

China Medical University

Publications: 21

Yang Chang Wu

Yang Chang Wu

China Medical University

Publications: 18

Fuu Jen Tsai

Fuu Jen Tsai

China Medical University

Publications: 16

Yueh-Hsiung Kuo

Yueh-Hsiung Kuo

China Medical University

Publications: 15

Susan L. Morris-Natschke

Susan L. Morris-Natschke

University of North Carolina at Chapel Hill

Publications: 15

Tian Shung Wu

Tian Shung Wu

National Cheng Kung University

Publications: 13

Ernest Hamel

Ernest Hamel

National Institutes of Health

Publications: 13

Mien Chie Hung

Mien Chie Hung

China Medical University

Publications: 12

Fang Rong Chang

Fang Rong Chang

Kaohsiung Medical University

Publications: 12

Yitao Wang

Yitao Wang

University of Macau

Publications: 12

Trending Scientists

Ronald P. Sansone

Ronald P. Sansone

Pitney Bowes (France)

Víctor Yepes

Víctor Yepes

Universitat Politècnica de València

Navid Mostoufi

Navid Mostoufi

University of Tehran

Anne-Marie Caminade

Anne-Marie Caminade

Centre national de la recherche scientifique, CNRS

Jack F. Douglas

Jack F. Douglas

National Institute of Standards and Technology

Robert Kostecki

Robert Kostecki

Lawrence Berkeley National Laboratory

H.W. Schock

H.W. Schock

University of Stuttgart

John L. Provis

John L. Provis

University of Sheffield

Thomas Hovestadt

Thomas Hovestadt

University of Würzburg

Alessandro Finazzi-Agrò

Alessandro Finazzi-Agrò

University of Rome Tor Vergata

James Palis

James Palis

University of Rochester Medical Center

Vincent Pettigrove

Vincent Pettigrove

RMIT University

Marianne B. Müller

Marianne B. Müller

Johannes Gutenberg University of Mainz

Nadia Solowij

Nadia Solowij

University of Wollongong

Bert A. Rockman

Bert A. Rockman

Purdue University West Lafayette

Kaike Pan

Kaike Pan

New Mexico State University

Something went wrong. Please try again later.